NCT07151911View on ClinicalTrials.gov

Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2031

Conditions
Breast Cancer
Interventions
DRUG

abemaciclib, olaparib and endocrine therapy

Patients receiving abemaciclib, olaparib and endocrine therapy.

Trial Locations (1)

41124

RECRUITING

Azienda Ospedaliero Universitaria Policlinico di Modena, Modena

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria di Modena

OTHER